1. Home
  2. MGIH vs AFMD Comparison

MGIH vs AFMD Comparison

Compare MGIH & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGIH
  • AFMD
  • Stock Information
  • Founded
  • MGIH 1978
  • AFMD 2000
  • Country
  • MGIH Hong Kong
  • AFMD Germany
  • Employees
  • MGIH N/A
  • AFMD N/A
  • Industry
  • MGIH Publishing
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • MGIH Consumer Discretionary
  • AFMD Health Care
  • Exchange
  • MGIH Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • MGIH 20.5M
  • AFMD 17.0M
  • IPO Year
  • MGIH 2023
  • AFMD 2014
  • Fundamental
  • Price
  • MGIH $1.67
  • AFMD $1.04
  • Analyst Decision
  • MGIH
  • AFMD Strong Buy
  • Analyst Count
  • MGIH 0
  • AFMD 5
  • Target Price
  • MGIH N/A
  • AFMD $13.50
  • AVG Volume (30 Days)
  • MGIH 55.0K
  • AFMD 131.9K
  • Earning Date
  • MGIH 10-30-2024
  • AFMD 03-27-2025
  • Dividend Yield
  • MGIH N/A
  • AFMD N/A
  • EPS Growth
  • MGIH N/A
  • AFMD N/A
  • EPS
  • MGIH N/A
  • AFMD N/A
  • Revenue
  • MGIH $38,530,773.00
  • AFMD $6,287,085.00
  • Revenue This Year
  • MGIH N/A
  • AFMD N/A
  • Revenue Next Year
  • MGIH N/A
  • AFMD $225.65
  • P/E Ratio
  • MGIH N/A
  • AFMD N/A
  • Revenue Growth
  • MGIH N/A
  • AFMD N/A
  • 52 Week Low
  • MGIH $1.19
  • AFMD $0.92
  • 52 Week High
  • MGIH $6.83
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • MGIH 50.94
  • AFMD 38.98
  • Support Level
  • MGIH $1.47
  • AFMD $0.98
  • Resistance Level
  • MGIH $1.64
  • AFMD $1.09
  • Average True Range (ATR)
  • MGIH 0.21
  • AFMD 0.06
  • MACD
  • MGIH -0.01
  • AFMD 0.03
  • Stochastic Oscillator
  • MGIH 29.85
  • AFMD 64.03

About MGIH Millennium Group International Holdings Limited

Millennium Group International Holdings Ltd is a paper-based packaging solutions supplier. It offers paper-based inner and outer packaging products which can be broadly categorized into packaging products, Packaging products supply chain management solutions and corrugated products.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: